Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Cancer Prev Res (Phila). 2021 Nov 8;15(2):129–138. doi: 10.1158/1940-6207.CAPR-21-0399

Fig. 1.

Fig. 1.

Trial design and measurement of ASA metabolites. A, Summary of randomized controlled trial, procedures and analyses performed. B, Mean plasma salicylate levels in pre- and post-trial samples from subjects in the placebo and two ASA cohorts. Error bars indicate SEM. C, Mean plasma salicylurate levels in pre- and post-trial samples. Error bars indicate SEM.